These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32398906)

  • 21. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
    Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
    Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Preterm Gut Microbiota: An Inconspicuous Challenge in Nutritional Neonatal Care.
    Henderickx JGE; Zwittink RD; van Lingen RA; Knol J; Belzer C
    Front Cell Infect Microbiol; 2019; 9():85. PubMed ID: 31001489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ayurveda and botanical drugs for epilepsy: Current evidence and future prospects.
    Sriranjini SJ; Sandhya K; Mamta VS
    Epilepsy Behav; 2015 Nov; 52(Pt B):290-6. PubMed ID: 26141933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases.
    Harsch IA; Konturek PC
    Med Sci (Basel); 2018 Apr; 6(2):. PubMed ID: 29673211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the Role of Human Gut Microbiota in
    Kachrimanidou M; Tsintarakis E
    Microorganisms; 2020 Jan; 8(2):. PubMed ID: 32023967
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs.
    Choi MS; Yu JS; Yoo HH; Kim DH
    Pharmacol Res; 2018 Apr; 130():164-171. PubMed ID: 29391236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross comparison between Ayurvedic etiology of Major Depressive Disorder and bidirectional effect of gut dysregulation.
    Steer E
    J Ayurveda Integr Med; 2019; 10(1):59-66. PubMed ID: 30655102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of gut microbiota in research of Chinese medicines].
    Jiang DJ; Zhang L; Cao YD; Yao WF
    Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(17):3218-3225. PubMed ID: 28920373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus.
    Zhang B; Yue R; Chen Y; Yang M; Huang X; Shui J; Peng Y; Chin J
    Evid Based Complement Alternat Med; 2019; 2019():2634898. PubMed ID: 30906411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota, a new frontier to understand traditional Chinese medicines.
    Feng W; Ao H; Peng C; Yan D
    Pharmacol Res; 2019 Apr; 142():176-191. PubMed ID: 30818043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota and immune crosstalk in metabolic disease.
    Burcelin R
    Mol Metab; 2016 Sep; 5(9):771-81. PubMed ID: 27617200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.
    Yue SJ; Wang WX; Yu JG; Chen YY; Shi XQ; Yan D; Zhou GS; Zhang L; Wang CY; Duan JA; Tang YP
    Pharmacol Res; 2019 Oct; 148():104453. PubMed ID: 31541688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease.
    Naseer MI; Bibi F; Alqahtani MH; Chaudhary AG; Azhar EI; Kamal MA; Yasir M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):305-11. PubMed ID: 24059313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PPAR-microbiota-metabolic organ trilogy to fine-tune physiology.
    Oh HYP; Visvalingam V; Wahli W
    FASEB J; 2019 Sep; 33(9):9706-9730. PubMed ID: 31237779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal MicrobiOMICS to define health and disease in human and mice.
    Serino M; Chabo C; Burcelin R
    Curr Pharm Biotechnol; 2012 Apr; 13(5):746-58. PubMed ID: 22122483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.